Pediatrics · LP-007
Multivitamin Syrup
Medicine dossier. Catalogue identity is separated from unresolved product-specific fields and from external scientific references.
Development record
This dossier integrates an archived editorial source review dated 2026-09-11. Website reconciliation does not constitute a new medical or regulatory review. Controlled product approval, use instructions and supply status remain unestablished.
- Portfolio reference
- LP-007Pediatrics
- Generic identity
- MultivitaminSyrup
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Layers 01–02 · Evidence boundary
What this public record establishes — and what remains held.
- Portfolio reference
- LP-007
- Generic identity
- Multivitamin
- Presentation
- Syrup
- Catalogue strength
- Vitamins A, D, E, C, B1, B2, B3, B5, B6, B12; quantities per approved registration
- Catalogue pack
- Bottle 60 mL / 100 mL
- Public status
- Development presentation
Layer 01 · Controlled catalogue facts
- Catalogue identity: multivitamin.
- Dosage form: syrup.
- Strength field says “Pediatric multivitamin formula per approved registration”.
- Catalogue pack options: bottle 60 mL and bottle 100 mL.
Layer 02 · Unresolved product-specific fields
- Actual active ingredient list and quantitative composition.
- Whether the product is regulated as a medicine, supplement or another category in each destination.
- Any approved registration/authorisation referenced by the source wording.
- Age range, indication/claims, excipients, measuring instructions, storage, shelf life and supply status.
Identity note
B01 issue P003 remains open. No external multivitamin reference can identify the missing LP-007 composition.
02 · Variants
Preserve each catalogue row without inferring missing SKU relationships.
| Variant | Proposed strength / concentration | Dosage form | Presentation detail | Pack relationship | Evidence status |
|---|---|---|---|---|---|
| A | Formula not supplied | Syrup | — | Bottle 60 mL | Pack option is explicit; composition and regulatory category are unresolved. |
| B | Formula not supplied | Syrup | — | Bottle 100 mL | Pack option is explicit; composition and regulatory category are unresolved. |
The table reproduces or structures catalogue-level fields. It does not create an approved SKU, instruction or specification where the source record does not provide one.
03 · External reference context
Ingredient and dosage-form background
Multivitamin describes a category of products, not a single standardized ingredient or formula. The clinical meaning depends on the exact vitamins, their chemical forms and amounts, and whether minerals are included. The current catalogue does not specify that composition. It would therefore be misleading to claim particular nutritional benefits, deficiency treatment, pediatric suitability or equivalence to another multivitamin on the basis of the product-family name alone.
Clinical context and therapeutic role
A nutrition assessment considers dietary intake, age, growth, malabsorption, medical conditions and any identified deficiency. A multivitamin may help address selected dietary gaps, but it does not replace food or establish treatment for unexplained fatigue, poor growth or recurrent illness. Targeted deficiency treatment may require a different product and clinical monitoring. Professional review should begin with a complete proposed formula and evidence supporting each intended population and claim.
Selected safety context
Excess intake can be harmful, particularly when several supplements overlap. Fat-soluble vitamins can accumulate, and any mineral content may introduce additional risks and interactions. If iron is included, accidental ingestion by a child can be particularly dangerous; its presence is not confirmed here. Ingredient-specific allergies and suitability of sweeteners or other excipients must be checked from the finalized label. Keep all supplement and medicine bottles out of children’s reach.
Selected external context only. It is not a complete risk profile or Luang Pharma approved labelling. The exact authorised IFU/label and applicable professional guidance control product use.
Formulation, presentation and handling evidence
This is a proposed liquid oral presentation with a stated concentration. The liquid vehicle, sweeteners, preservatives and whether the medicine requires shaking must be verified from the final label. A liquid format does not, by itself, establish that all age groups are eligible.
Use the product’s appropriate calibrated oral measuring device and verify concentration each time a new bottle is supplied. Keep the cap and label intact. Follow the actual instructions for storage and any period after opening; do not transfer advice from another brand or concentration.
Final instructions, storage conditions, shelf life and any after-opening/in-use limits require the exact controlled product documentation; none is created from a comparator reference.
Points for professional review
A pediatric clinician or pharmacist should confirm the diagnosis, authorized age range, weight-related assessment where relevant, concentration and measuring device. Catalogue placement in a pediatric category is not evidence of approval for children.
04 · Layer 04 · Documentation gate
Controlled product documents must close the held fields.
Before this medicine record can support product-specific clinical, technical or supply claims, the exact finished-product documentation must resolve the held fields.
Complete qualitative and quantitative formula.
Controlled regulatory classification and approved claims/label for the intended market.
Finished-product specification, container/closure and measuring-device information.
Registration/market-status evidence if a registration claim is to be made.
Editorial source check: archived record dated 2026-09-11.
Qualified product/medical review: Not recorded at B07a checkpoint
Approved Luang Pharma label: Not provided or established
Registration / availability / supply: not established by this public record.
05 · Layer 03 · Sources & review
External references are attributed, not adopted as Luang Pharma labelling.
| Source | Recorded revision / check | How it is used |
|---|---|---|
| NIH Office of Dietary Supplements: Multivitamin/mineral supplementsArchived source classification: US government nutrition reference | Archived access check: 2026-09-11 | External composition/context reference only; it cannot identify the ingredients or regulatory category of LP-007. |
External sources may describe authorised products, public-health guidance or device classes. They do not establish equivalence, approval, model performance, manufacturing status or supply eligibility for LP-007.
Professional enquiries
Request product-specific evidence for LP-007.
State the exact presentation or configuration, organisation, destination and evidence you need. The public portfolio record is not an offer of supply.